NASH
Clinical trials for NASH explained in plain language.
Never miss a new study
Get alerted when new NASH trials appear
Sign up with your email to follow new studies for NASH, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New pill aims to shrink dangerous liver fat
Disease control Recruiting nowThis study is testing an investigational pill called CS060380 to see if it can safely reduce liver fat and improve health in people with non-alcoholic steatohepatitis (NASH), a serious form of fatty liver disease. About 120 adults will take either the study drug or a placebo (a d…
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Cascade Pharmaceuticals, Inc • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Old heart drug could be new hope for millions with fatty liver
Disease control Recruiting nowThis study is testing if digoxin, a medication used for heart conditions, can help treat a serious liver disease called NASH (now called MASH). Researchers will give 144 people with NASH either digoxin or a placebo pill daily for 24 weeks to see if it reduces liver inflammation a…
Matched conditions: NASH
Phase: PHASE2 • Sponsor: Yale University • Aim: Disease control
Last updated Mar 31, 2026 12:11 UTC
-
Scientists hunt genetic clues to predict deadly liver cancer
Knowledge-focused Recruiting nowThis study aims to understand why some people with fatty liver disease develop liver cancer. Researchers will study 500 adults with fatty liver disease to see how specific genes and family history affect cancer risk. The goal is to create a tool to identify high-risk individuals …
Matched conditions: NASH
Phase: NA • Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:11 UTC
-
First human test for promising liver disease drug begins
Knowledge-focused Recruiting nowThis is the first study testing a new drug called BAR502 in humans. Researchers will give the drug to 52 healthy volunteers to check if it's safe and see how the body processes it. The goal is to gather basic information to potentially develop a treatment for NASH, a serious live…
Matched conditions: NASH
Phase: PHASE1 • Sponsor: BAR Pharmaceuticals s.r.l. • Aim: Knowledge-focused
Last updated Mar 30, 2026 14:33 UTC